Ryan Zimmerman is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on LENSAR (LNSR – Research Report), with a price target of $15.00. The company’s shares closed yesterday at $13.99.

In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on RxSight (RXST – Research Report), with a price target of $44.00. The company’s shares closed yesterday at ...

On Tuesday, Treace Medical (TASE:PMCN) Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price ...

With that in mind, there is no other place to start than with a moment by the franchises most iconic player, Ryan Zimmerman. Let’s rewind the clock back to March 30th, 2008, and re-live the ...